|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 221/16 | |
| C07D 401/12 | |||
| C07D 405/12 | |||
| A61K 31/444 | |||
| A61K 31/435 | |||
| A61P 3/10 |
| (11) | Patento numeris | 3055288 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14852689.0 |
| Europos patento paraiškos padavimo data | 2014-09-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-08-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2014/087857 |
| Data | 2014-09-30 |
| (87) | Numeris | WO 2015/051725 |
| Data | 2015-04-16 |
| (30) | Numeris | Data | Šalis |
| PCT/CN2013/0848 | 2013-10-08 | WO |
| (72) |
BIFTU, Tesfaye, US
BIJU, Purakkatle, US
COLLETTI, Steven L., US
CUI, Mingxiang, CN
HAGMANN, William K., US
HU, Bin, CN
JOSIEN, Hubert, US
KAR, Nam Fung, US
NAIR, Anilkumar, US
NARGUND, Ravi, US
SPERBECK, Donald M., US
ZHU, Chen, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065,
US
|
| (54) | ANTIDIABETIC TRICYCLIC COMPOUNDS |
| ANTIDIABETIC TRICYCLIC COMPOUNDS |